After a year of turmoil, cancer researchers see promising signs for mRNA vaccines
Cancer researchers are optimistic about the future of mRNA vaccines, despite a tumultuous 12 months that saw political backlash and funding cuts. The mRNA-based Covid vaccines produced by Pfizer and Moderna have helped blunt the impact of the pandemic, but they have also sparked political backlash that has threatened to slow or derail dozens of potential cancer treatments.
One patient, Vita Sara Blechner, a middle school librarian from Oceanside, New York, turned to mRNA-based cancer vaccines after being diagnosed with pancreatic cancer. Her story highlights the potential of mRNA vaccines to provide personalized treatment for cancer patients. Dr. Vinod Balachandran, director of MSK’s Olayan Center for Cancer Vaccines, has been working on an mRNA-based vaccine against pancreatic cancer, in combination with standard immunotherapy and chemotherapy.
The trial, which included 16 patients, showed that eight patients showed a dramatic immune response to the mRNA-based vaccine. Seven of the eight are alive and well six years after the trial began, a finding that was to be presented Monday at the American Association of Cancer Research meeting in San Diego.
The field of mRNA cancer vaccines has faced challenges, including political backlash and funding cuts. However, researchers are optimistic about the future of mRNA vaccines, and federal research grants have started to flow again after major interruptions over the past several months.
Despite the challenges, researchers are confident that mRNA vaccines will play a crucial role in the future of cancer treatment. Dr. Robert Vonderheide, director of the Abramson Cancer Center at the University of Pennsylvania, says that the field took hits last year but that public pressure turned the tide. "The entire country has been asking, 'How valuable is cancer research to our society?' And what we heard from the public and our patients is, it’s super-important."
In conclusion, mRNA vaccines have shown promise in cancer research, and despite challenges, researchers are optimistic about their future role in cancer treatment.
